DTwP-HB-Hib: antibody persistence after a primary series, immune response and safety after a booster dose in children 18-24 months old

• Main Authors: Hartono Gunardi (Author), Kusnandi Rusmil (Author), Eddy Fadlyana (Author), Soedjatmiko (Author), Meita Dhamayanti (Author), Rini Sekartini (Author), Rodman Tarigan (Author), Hindra Irawan Satari (Author), Bernie Endyarni Medise (Author), Rini Mulia Sari (Author), Novilia Sjafri Bachtiar (Author), Cissy B. Kartasasmita (Author), Sri Rezeki S. Hadinegoro (Author)
• Format: Book
• Published: BMC, 2018-05-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background The new combination of DTwP-HB-Hib vaccines has been developed in Indonesia following World Health Organization (WHO) recommendation and integrated into national immunization program. The aims of the study were to measure 1) antibody persistence 12-18 months after a primary serie...